Shared decision making in the treatment of multiple sclerosis

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease in the central nervous system, which usually begins with relapsing–remitting course followed by insidious disability worsening. There is currently no cure for MS, but given the increasing numbers of available disease–modifying drugs with differences in risks and benefits, shared decision making (SDM) in the treatment of MS seems to be essential to offer the optimum outcome and improve the quality of life in patients with MS. The aim of this symposium is to review the concept of SDM and discuss main challenges in clinical care of MS patients.